Deal expands pharmaceutical company’s portfolio of cancer drugs
Read Full ArticleBeiGene tumbled 16% in its mainland trading debut, after raising $3.5 billion and becoming the first company to be tr...
Read Full ArticleCopyright © 2023 All rights reserved. Legitimate Limited.